| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 938 |
| 1 | CYCLOPHOSPHAMIDE | 797 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 797 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 797 |
| 4 | PREDNISONE | 628 |
| 5 | DOXORUBICIN | 609 |
| 6 | PREDNISOLONE | 411 |
| 7 | PREDNISOLONE ORAL | 411 |
| 8 | PREDNISOLONE ORAL SOLUTION | 411 |
| 9 | LAMIVUDINE | 402 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PREDNISOLONE SODIUM PHOSPHATE | 93 | 0.0373 |
| 1 | ADEFOVIR DIPIVOXIL | 43 | 0.0338 |
| 2 | CABOTEGRAVIR SODIUM | 54 | 0.0336 |
| 3 | LAMIVUDINE | 402 | 0.0159 |
| 4 | ENTECAVIR | 170 | 0.0144 |
| 5 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 1 | 0.0139 |
| 6 | RILPIVIRINE | 75 | 0.0105 |
| 7 | BLEOMYCIN SULFATE | 107 | 0.0103 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 88 | 0.0102 |
| 9 | DOXORUBICIN HYDROCHLORIDE | 240 | 0.0073 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 532 | 0.0108 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 38 | 0.0065 |
| 2 | Vasopressin Receptor Agonist [EPC] | 2 | 0.0060 |
| 3 | CD4-directed Blocking Antibody [EPC] | 3 | 0.0056 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 466 | 0.0042 |
| 5 | Alkylating Drug [EPC] | 873 | 0.0036 |
| 6 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 186 | 0.0035 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 16 | 0.0034 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 979 | 0.0031 |
| 9 | Topoisomerase Inhibitor [EPC] | 215 | 0.0028 |